HLB Genex CEO Kim Do-yeon's Shareholding Increases by 32,567 Shares, Ownership Stake Rises 0.10 Percentage Points

HLB Genex (187420), a biotech materials specialist, reported on July 16 that CEO Kim Do-yeon's shareholding increased by 32,567 shares, raising his ownership stake from 0.18% to 0.28%. The shares were acquired via market purchases at 1,476 won each. The company's financials as of December 2025 show total assets of 135.8 billion won, liabilities of 81.1 billion won, and net income of 22.9 billion won. Its stock closed at 1,706 won on July 16, down 194 won (-10.21%) from the previous day.